Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Split into two doses if using higher amounts
Long-term monitoring: We see patients at 1, 3, 6, and 12 months post-GLP-1
With commercial insurance and a manufacturer savings card, Wegovy and Zepbound can cost as little as $25 per fill
All regulatory agencies are awaiting Phase 3 data Phase 2 results: Up to 24.2% weight loss at 48 weeks, the highest efficacy data for any GLP-1 class medication Commercial launch timeline: FDA submission expected 2026-2027, with 6-12 month review period International rollout: EMA (Europe) and TGA (Australia) typically follow FDA approval within 6-18 months Is retatrutide available
US$ 25.72
US$ 20.15
US$ 26.59
US$ 22.30
US$ 23.56
US$ 26.70
US$ 27.17
US$ 20.79
![Unblinking Observer [Innistrad: Double Feature] TG17](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/cc734757-19b1-52cb-b1be-969b87902c12_152b2245-ccad-4498-9663-01eff3cd5a9c.png?v=1697568733)
![Retrieve [Innistrad: Double Feature] Fire [+30]](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/4b80c571-e062-5e4e-b0f7-4d5a4d815bbc_cd5eab0f-45bd-48fe-bc61-734293ee4b72.png?v=1697568758)
![Stolen Vitality [Innistrad: Double Feature] Viashino Warlock](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/9809840e-4193-588e-96d3-994a0027108f_a6b5fdca-4ca1-4e36-b4f0-f74a602efa74.png?v=1697568746)